185 related articles for article (PubMed ID: 9123201)
21. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2.
Onodera K; Chandraker A; Volk HD; Ritter T; Lehmann M; Kato H; Sayegh MH; Kupiec-Weglinski JW
Transplantation; 1999 Jul; 68(2):288-93. PubMed ID: 10440403
[TBL] [Abstract][Full Text] [Related]
22. Intrathymic injection of allogeneic cells induces indefinite survival of cardiac but not small bowel grafts.
Xia W; Sayegh MH; Kirkman RL
Transplant Proc; 1994 Jun; 26(3):1581. PubMed ID: 8030045
[No Abstract] [Full Text] [Related]
23. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
Guillot C; Mathieu P; Coathalem H; Le Mauff B; Castro MG; Tesson L; Usal C; Laumonier T; Brouard S; Soulillou JP; Lowenstein PR; Cuturi MC; Anegon I
J Immunol; 2000 May; 164(10):5258-68. PubMed ID: 10799887
[TBL] [Abstract][Full Text] [Related]
24. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.
Dengler TJ; Szabo G; Sido B; Nottmeyer W; Zimmerman R; Vahl CF; Hünig T; Meuer SC
Transplantation; 1999 Feb; 67(3):392-8. PubMed ID: 10030284
[TBL] [Abstract][Full Text] [Related]
25. Distinct tolerance pathways in sensitized rat recipients after blockade of activation signal 1 and signal 2.
Onodera K; Chandraker A; Kato H; Volk HD; Sayegh MH; Kupiec-Weglinski JW
Transplant Proc; 1999; 31(1-2):876-7. PubMed ID: 10083384
[No Abstract] [Full Text] [Related]
26. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA
Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396
[TBL] [Abstract][Full Text] [Related]
27. CTLA4Ig inhibits alloantibody responses to transfusions and transplants.
Ibrahim S; Jakobs F; Linsley PS; Sanfilippo F; Baldwin WM
Transplant Proc; 1997; 29(1-2):1025. PubMed ID: 9123179
[No Abstract] [Full Text] [Related]
28. Effect of simultaneous intrathymic injection of two unrelated cellular alloantigens on rat cardiac allograft survival.
Shimomura K; Hardy MA; Oluwole SF
Transplant Proc; 1995 Feb; 27(1):127. PubMed ID: 7878878
[No Abstract] [Full Text] [Related]
29. Prevention of acute lung allograft rejection in rat by CTLA4Ig.
Shiraishi T; Yasunami Y; Takehara M; Uede T; Kawahara K; Shirakusa T
Am J Transplant; 2002 Mar; 2(3):223-8. PubMed ID: 12096784
[TBL] [Abstract][Full Text] [Related]
30. Lethal graft-vs-host disease after cyclosporine therapy in recipients of sensitized small bowel allografts.
Langrehr JM; Markus PM; Lee TK; Müller AR; Banner B; Lee KK; Schraut WH
Transplant Proc; 1992 Jun; 24(3):1138. PubMed ID: 1604556
[No Abstract] [Full Text] [Related]
31. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
Akalin E; Chandraker A; Russell ME; Turka LA; Hancock WW; Sayegh MH
Transplantation; 1996 Dec; 62(12):1942-5. PubMed ID: 8990393
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection.
Nadeau K; Azuma H; Chandraker A; Sayegh MH; Tilney NL
Transplant Proc; 1997; 29(1-2):1038. PubMed ID: 9123187
[No Abstract] [Full Text] [Related]
33. Adenovirus-mediated gene transfer of CTLA4Ig to liver allografts results in prolonged survival and local T-cell anergy.
Olthoff KM; Da Chen X; Gelman A; Turka L; Shaked A
Transplant Proc; 1997; 29(1-2):1030-1. PubMed ID: 9123183
[No Abstract] [Full Text] [Related]
34. CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients.
Kato H; Onodera K; Chandraker A; Volk HD; Sayegh MH; Kupiec-Weglinski JW
Transplant Proc; 1998 Jun; 30(4):1063-4. PubMed ID: 9636430
[No Abstract] [Full Text] [Related]
35. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
[TBL] [Abstract][Full Text] [Related]
36. Tolerance to a second donor-matched allograft following local immune modulation using transfer of sequences encoding CTLA4Ig.
Shaked A; Olthoff K; Sellers M; Chen XD; Gelman A
Transplant Proc; 1997; 29(1-2):1026. PubMed ID: 9123180
[No Abstract] [Full Text] [Related]
37. Reversal of CTLA4Ig-mediated tolerance to cardiac allografts by exogenous interleukin-2.
Arima T; Rehman A; Flye MW
Transplant Proc; 1997; 29(1-2):1305-6. PubMed ID: 9123318
[No Abstract] [Full Text] [Related]
38. Impact of different forms of recipient antigen and different routes of antigen administration in donor pretreatment for preventing graft-versus-host disease in rat small bowel transplantation.
He G; Wang M; Xu H; Tian L; Yu J; Stepkowski SM; Kahan BD
Transplant Proc; 1996 Oct; 28(5):2469. PubMed ID: 8907906
[No Abstract] [Full Text] [Related]
39. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
Bolling SF; Lin H; Wei RQ; Turka LA
J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of adenovirus-mediated gene transfer with CTLA4Ig in allo and xeno-transplantation.
Hayashi S; Dai-Kaku L; Namii Y; Kato T; Tokoro T; Kobayashi T; Yokoyama I; Hamada H; Nakao A
Transplant Proc; 2000 Nov; 32(7):2520-1. PubMed ID: 11120276
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
